Literature DB >> 8688694

Managing early presentation of rheumatoid arthritis. Systematic overview.

R Glazier1.   

Abstract

OBJECTIVE: To describe evidence-based management of patients presenting to family physicians with typical signs and symptoms of recent onset of rheumatoid arthritis (RA). STUDY SELECTION: Articles for critical review were included if relevant to primary care management of early RA (less than 1 year duration). Sources included MEDLINE from 1966 to December 1995, the reference library of the Arthritis Community Research and Evaluation Unit, and conference abstracts.
FINDINGS: Evidence from randomized, controlled trials supports the short-term benefit of nonsteroidal anti-inflammatory drugs, disease-modifying agents for rheumatic diseases, intravenous pulse corticosteroid therapy, intra-articular therapy, aerobic exercise, patient education, psychologic intervention, home physiotherapy, home occupational therapy, and rehabilitation programs. Some evidence favours acetaminophen for analgesia, low-dose oral corticosteroids for symptom control, and referral to a rheumatologist. Evidence for rest, ice, and heat for symptom control is conflicting and based on low-quality studies.
CONCLUSION: Family physicians play an important role in establishing early and accurate diagnosis of RA, coordinating therapy, and providing ongoing support, education, and monitoring to patients and their families.

Entities:  

Mesh:

Year:  1996        PMID: 8688694      PMCID: PMC2146390     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  68 in total

1.  Paraffin-wax baths in the treatment of rheumatoid arthritis.

Authors:  R HARRIS; J B MILLARD
Journal:  Ann Rheum Dis       Date:  1955-09       Impact factor: 19.103

2.  A double-blind comparison of the gastroduodenal safety and efficacy of diclofenac and a fixed dose combination of diclofenac and misoprostol in the treatment of rheumatoid arthritis.

Authors:  W Verdickt; C Moran; H Hantzschel; A M Fraga; H Stead; G S Geis
Journal:  Scand J Rheumatol       Date:  1992       Impact factor: 3.641

3.  Early rheumatoid disease. I. Onset.

Authors:  A Fleming; J M Crown; M Corbett
Journal:  Ann Rheum Dis       Date:  1976-08       Impact factor: 19.103

4.  Meta-analysis of NSAIDs: contribution of drugs, doses, trial designs, and meta-analytic techniques.

Authors:  P C Gøtzsche
Journal:  Scand J Rheumatol       Date:  1993       Impact factor: 3.641

5.  Anaemia and chronic disease.

Authors:  D P Bentley
Journal:  Clin Haematol       Date:  1982-06

6.  'Baggietherapy':simple pain relief for arthritic knees.

Authors:  J Kangilaski
Journal:  JAMA       Date:  1981 Jul 24-31       Impact factor: 56.272

7.  Evaluation of a clinic education program for patients with rheumatoid arthritis.

Authors:  P J Vignos; W T Parker; H M Thompson
Journal:  J Rheumatol       Date:  1976-06       Impact factor: 4.666

8.  Cost-effectiveness of inpatient and intensive outpatient treatment of rheumatoid arthritis. A randomized, controlled trial.

Authors:  A Helewa; C Bombardier; C H Goldsmith; B Menchions; H A Smythe
Journal:  Arthritis Rheum       Date:  1989-12

9.  Use of short-term efficacy/toxicity tradeoffs to select second-line drugs in rheumatoid arthritis. A metaanalysis of published clinical trials.

Authors:  D T Felson; J J Anderson; R F Meenan
Journal:  Arthritis Rheum       Date:  1992-10

10.  Fatal upper gastrointestinal hemorrhage or perforation among users and nonusers of nonsteroidal anti-inflammatory drugs in Saskatchewan, Canada 1983.

Authors:  H A Guess; R West; L M Strand; D Helston; E G Lydick; U Bergman; K Wolski
Journal:  J Clin Epidemiol       Date:  1988       Impact factor: 6.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.